Abstract: . . .  to inflammation. The study was funded by a grant from Bristol-Myers Squibb and diaDexus, a Santa Clara, California-based company that manufactures a test for phospholipase A2. Combining the results of these studies with other known risk factors will help improve doctors' ability to predict heart disease risk, researchers say. "It is now generally recognized that although the use of traditional risk factors (like elevated cholesterol, high blood pressure and obesity) produces reasonably accurate estimates of risk in populations, this approach allows clinicians to predict only about . . .
--629,1,314,712,3145